24HourWire

24HourWire

News from all angles

STAT News Center

STAT+: FDA discloses reasons for rejecting Summit drug

The FDA published its complete response letter to Summit Therapeutics explaining why it rejected the biotech's closely watched lung cancer drug:

Redirecting to STAT News in 3 seconds...

Read Now → Explore 24HourWire

Share this story with your network